What is he best known for?
The fields of study he is best known for:
- Gene
- Enzyme
- Internal medicine
His primary areas of study are Cell biology, Growth factor, Cartilage oligomeric matrix protein, ADAMTS and Cartilage.
His studies deal with areas such as Biochemistry and Arthritis as well as Cell biology.
His Growth factor research is multidisciplinary, incorporating elements of Tumor necrosis factor alpha, Immunology, Fibroblast growth factor receptor 3, Chondrocyte and Fibroblast growth factor receptor.
His Chondrocyte research includes themes of Chondrogenesis, Cancer research and Cellular differentiation.
Chuan-ju Liu has researched ADAMTS in several fields, including Plasma protein binding and Small interfering RNA.
His research integrates issues of Epidermal growth factor and Granulin in his study of Cartilage.
His most cited work include:
- The Growth Factor Progranulin Binds to TNF Receptors and Is Therapeutic Against Inflammatory Arthritis in Mice (473 citations)
- miR-199a, a bone morphogenic protein 2-responsive MicroRNA, regulates chondrogenesis via direct targeting to Smad1. (202 citations)
- Serum interleukin-6 as a marker of periprosthetic infection following total hip and knee arthroplasty. (193 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Cell biology, Molecular biology, Immunology, Arthritis and Cancer research.
His research in Cell biology intersects with topics in Chondrocyte, Endocrinology, Growth factor and Internal medicine.
His biological study spans a wide range of topics, including MyoD, Reporter gene, Gene expression, Transcription factor and C2C12.
His studies in Arthritis integrate themes in fields like ADAMTS and Bioinformatics.
His Cancer research study which covers Pathology that intersects with Bone morphogenetic protein.
His Chondrogenesis study deals with Cellular differentiation intersecting with Bone morphogenetic protein 2.
He most often published in these fields:
- Cell biology (43.33%)
- Molecular biology (24.44%)
- Immunology (21.11%)
What were the highlights of his more recent work (between 2018-2021)?
- Cell biology (43.33%)
- Tumor necrosis factor alpha (15.56%)
- Chondrogenesis (17.22%)
In recent papers he was focusing on the following fields of study:
Chuan-ju Liu mainly focuses on Cell biology, Tumor necrosis factor alpha, Chondrogenesis, Cartilage and In vivo.
His Cell biology study combines topics from a wide range of disciplines, such as Chondrocyte, Transgene and Bone resorption.
His Chondrocyte study combines topics in areas such as Elastin and Growth factor.
The concepts of his Tumor necrosis factor alpha study are interwoven with issues in TUNEL assay, Bioinformatics, Inflammation, Pathogenesis and Arthritis.
Chuan-ju Liu interconnects Proinflammatory cytokine, Type 1 diabetes and Endocrinology in the investigation of issues within Chondrogenesis.
His Cartilage study incorporates themes from Derivative and Regeneration.
Between 2018 and 2021, his most popular works were:
- Progranulin: A conductor of receptors orchestra, a chaperone of lysosomal enzymes and a therapeutic target for multiple diseases. (17 citations)
- Progranulin deficiency exacerbates spinal cord injury by promoting neuroinflammation and cell apoptosis in mice (12 citations)
- Lipoatrophy and metabolic disturbance in mice with adipose-specific deletion of kindlin-2 (12 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Internal medicine
His primary areas of investigation include Tumor necrosis factor alpha, Inflammation, Conditional gene knockout, Receptor and Pathology.
The various areas that Chuan-ju Liu examines in his Tumor necrosis factor alpha study include TUNEL assay, Ankylosing spondylitis, Mediator, Pharmacology and In vivo.
His study in Inflammation is interdisciplinary in nature, drawing from both Extracellular matrix, H&E stain and Intracellular.
His Conditional gene knockout research incorporates elements of Adipose tissue, Internal medicine and Endocrinology.
His work carried out in the field of Receptor brings together such families of science as Clinical trial, Bioinformatics, Pathogenesis, Adverse effect and Immune system.
His research on Arthritis focuses in particular on Inflammatory arthritis.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
